Literature DB >> 4711886

Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.

L Adamson, S H Curry, P K Bridges, A F Firestone, N I Lavin, D M Lewis, R D Watson, C M Xavier, J A Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4711886

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN： 0012-3714


× No keyword cloud information.
  4 in total

1.  Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.

Authors:  S H Curry; R Whelpton; P J de Schepper; S Vranckx; A A Schiff
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

Review 2.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

3.  Formation of chlorpromazine sulphoxide and monodesmethylchlorpromazine by microsomes of small intestine.

Authors:  R Knoll; W Christ; B Müller-Oerlinghausen; H Coper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

Review 4.  Depot antipsychotic drugs. Place in therapy.

Authors:  J M Davis; L Matalon; M D Watanabe; L Blake; L ] Metalon L [corrected to Matalon
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.